Thyroid cancer awareness month: Risk factors and early symptoms

The study found that Opdivo and Abraxane were effective and safe in treating muscle-invasive bladder cancer.Opdivo (nivolumab) with Abraxane (nab-paclitaxel) could expand the therapeutic opportunities of immune chemotherapy in patients with muscle-invasive bladder cancer (MIBC), according to results from the NURE-Combo trial.“The NURE-Combo trial provided insights into the potential value of expanding chemotherapy combinations with ICI in the setting of...